| Sharp Health Plan - All plan years |
| Xuriden (uridine triacetate) |
| Drugs that Alter Metabolism : Drugs that Alter Metabolism |
- Quantity Limit: limit maximum 1 EA PER 1 day(s)
- Chronic Lymphocytic Leukemia:
Duration: 12 Month(s)
Documented Diagnosis: Yes
Medical Test Required: Yes
Reauthorization Required: Yes
Duration of Reauthorization: = 12 month(s)
Drug Policy Based On: Payer Specific
Supporting Documentation Requirements: Lab Tests
Diagnosis Types: 1 of CLL for relapsed/refractory disease;Small Lymphocytic Lymphoma
Mantle Cell Lymphoma:
Age Requirement: > 19
Duration: 12 Month(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: Yes
Duration of Reauthorization: = 12 month(s)
|